FASEB 1992 In Anaheim: Getting The Message Into Cells

While hallway conversations may turn to federal biotech streamlining, this year's Federation of American Societies for Experimental Biology meeting programs will be heavy on basic research, with the theme of "growth factors, receptors, and signal transduction." FASEB is expecting 13,000 researchers, students, and exhibitors to converge on Anaheim, Calif., from April 5 to April 9. More than 7,000 scientific reports will be delivered and companies will be displaying about 700 exhibits in the Anahe

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

While hallway conversations may turn to federal biotech streamlining, this year's Federation of American Societies for Experimental Biology meeting programs will be heavy on basic research, with the theme of "growth factors, receptors, and signal transduction." FASEB is expecting 13,000 researchers, students, and exhibitors to converge on Anaheim, Calif., from April 5 to April 9. More than 7,000 scientific reports will be delivered and companies will be displaying about 700 exhibits in the Anaheim Convention Center, which is within walking distance of Disneyland's Space Mountain and Sleeping Beauty's Castle for those so inclined. Meeting highlights are as follows:

* Space Station Freedom: Capabilities and plans for life sciences research (Sunday, April 5; Convention Center)

* Use of animals in research--communicating the need to the public (Sunday, April 5; Hilton hotel)

* Origin, evolution, and distribution of life in the universe

(Tuesday, April 7; Marriott~~~ hotel)

* Scientific misconduct: Are the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies